CORDIS
EU research results

CORDIS

English EN
European Initiative for basic research in Microbiology and Infectious Diseases

European Initiative for basic research in Microbiology and Infectious Diseases

Objective

The overall objective of EIMID-ITN is to train ten early stage researchers to join the next generation of world experts in the biology of infectious diseases and specifically in the mechanisms of host-pathogen interaction. The project will be carried out within the highly successful European collaboration EIMID (European Initiative for Basic Research in Microbiology and Infectious Diseases) that brings together five top research organisations in Europe active in the field of infectious diseases, including a world renowned industrial research centre. EIMID aims at reaching a critical mass on research in infectious diseases in Europe, capable of implementing a rapid and effective scientific reaction to emerging infections, and at fostering high level training in a Europe-wide collaborative network that will attract the best talents worldwide.
In EIMID-ITN, ten interlinked scientific projects will tackle 1. invasive bacterial infections including meningococcal disease; 2. bacterial diarrhoeal diseases; and 3. HIV replication. The common theme throughout is the bidirectional interplay between pathogen and host in immune control vs. disease development.
Selected fellows from all over the world will engage in a three-year training pathway encompassing: individual top level scientific projects (training-by-research), 1-2 stages in other EIMID labs for collaborative studies, science-related training activities such as participation to seminars, courses and congressess, common scientific meetings and networking (EIMID meeting), and common training courses in complementary and soft skills. The final goal is that of forming the leading scientists of tomorrow, possessing knowledge that goes beyond the specific scientific sectors of interest. To ensure this, the managing/training company ALTA (associated partner level 2) will implement and monitor the project progress with the help of an independent Visiting Researcher who will directly assist fellows’ progress.

Coordinator

GLAXOSMITHKLINE VACCINES SRL

Address

Via Fiorentina 1
53100 Siena

Italy

Activity type

Other

EU Contribution

€ 643 606,49

Administrative Contact

Isabel Delany (Dr.)

Participants (5)

Sort alphabetically

Sort by EU Contribution

Expand all

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 258 529,20

INSTITUT PASTEUR

France

EU Contribution

€ 509 486,70

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 509 437,20

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

Germany

EU Contribution

€ 460 025,20

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 281 492,40

Project information

Grant agreement ID: 264388

Status

Closed project

  • Start date

    1 October 2010

  • End date

    30 September 2014

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 662 577,19

  • EU contribution

    € 2 662 577,19

Coordinated by:

GLAXOSMITHKLINE VACCINES SRL

Italy